- Home
- LGO vs ATRA Comparison
LGO vs ATRA Comparison
Compare LGO & ATRA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LGO
- ATRA
- Stock Information
- Founded
- LGO 1988
- ATRA 2012
- Country
- LGO Canada
- ATRA United States
- Employees
- LGO N/A
- ATRA N/A
- Industry
- LGO
- ATRA Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- LGO
- ATRA Health Care
- Exchange
- LGO Nasdaq
- ATRA Nasdaq
- Market Cap
- LGO 95.8M
- ATRA 97.0M
- IPO Year
- LGO 2007
- ATRA 2014
- Fundamental
- Price
- LGO $1.10
- ATRA $11.94
- Analyst Decision
- LGO Strong Buy
- ATRA Strong Buy
- Analyst Count
- LGO 1
- ATRA 3
- Target Price
- LGO $3.70
- ATRA $21.00
- AVG Volume (30 Days)
- LGO 3.2M
- ATRA 59.6K
- Earning Date
- LGO 11-12-2025
- ATRA 11-06-2025
- Dividend Yield
- LGO N/A
- ATRA N/A
- EPS Growth
- LGO N/A
- ATRA N/A
- EPS
- LGO N/A
- ATRA 0.56
- Revenue
- LGO $108,526,000.00
- ATRA $188,667,000.00
- Revenue This Year
- LGO N/A
- ATRA N/A
- Revenue Next Year
- LGO $54.96
- ATRA N/A
- P/E Ratio
- LGO N/A
- ATRA $20.97
- Revenue Growth
- LGO N/A
- ATRA 202.41
- 52 Week Low
- LGO $1.04
- ATRA $5.01
- 52 Week High
- LGO $2.70
- ATRA $18.71
- Technical
- Relative Strength Index (RSI)
- LGO 38.17
- ATRA 39.38
- Support Level
- LGO $1.10
- ATRA $10.50
- Resistance Level
- LGO $1.19
- ATRA $15.30
- Average True Range (ATR)
- LGO 0.09
- ATRA 1.30
- MACD
- LGO -0.01
- ATRA -0.47
- Stochastic Oscillator
- LGO 23.53
- ATRA 22.83
About LGO Largo Inc.
Largo Inc is committed to the production and supply of high-quality vanadium products. The company is also focused on the advancement of renewable energy storage solutions through Largo Clean Energy and its vanadium redox flow battery technology. The Company is engaged in the mining, exploration, and development of mineral properties, predominantly in Brazil, through which it produces and supplies vanadium products VPURE Flake, VPURE+ Flake, and VPURE+ Powder. The company has operating segments: sales & trading, mine properties, which generates key revenue, corporate, exploration and evaluation properties, Clean Energy, and Largo Physical Vanadium.
About ATRA Atara Biotherapeutics Inc.
Atara Biotherapeutics Inc operates in the United States healthcare sector. It focuses on developing transformative therapies for patients with serious diseases, including solid tumors, hematologic cancers, and autoimmune diseases. It operates and manages business as one operating and reportable segment which is the business of developing therapeutics. The company's product candidates comprise Tab-cel, ATA188, and ATA3219 (CAR T Platform).